Mizuno Shohei

Affiliation and department：

Research field (1)： Hematology and oncology

Research theme for competitive and other funds (1)：

2021 - 2024 PVT1 RNAに着目した新たなリンパ腫の分子病態解明と新規標的治療への応用

Papers (128)：

Sho Shibata, Yasuyuki Arai, Tadakazu Kondo, Shohei Mizuno, Satoshi Yamasaki, Takashi Akasaka, Noriko Doki, Shuichi Ota, Yumiko Maruyama, Ken-Ichi Matsuoka, et al. Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemia. Cytotherapy. 2024
Sivasundaram Karnan, Ichiro Hanamura, Akinobu Ota, Lam Quang Vu, Kaori Uchino, Tomohiro Horio, Satsuki Murakami, Shohei Mizuno, Md Lutfur Rahman, Md Wahiduzzaman, et al. ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells. Cell death discovery. 2024. 10. 1. 56-56
Takaaki Konuma, Satoshi Yamasaki, Ken Ishiyama, Shohei Mizuno, Hiromi Hayashi, Naoyuki Uchida, Masashi Shimabukuro, Masatsugu Tanaka, Takuro Kuriyama, Makoto Onizuka, et al. Comparison of allogeneic transplant outcomes between matched sibling donors and alternative donors in patients over 50 years of age with acute myeloid leukemia: 8/8 allele-matched unrelated donors and unrelated cord blood provide better leukemia-free survival compared with matched sibling donors during non-remission status: MSD vs alternative donors transplant for patients over 50 years of age with AML. Transplantation and cellular therapy. 2023
Kotaro Shide, Katsuto Takenaka, Akira Kitanaka, Akihiko Numata, Takuro Kameda, Takuji Yamauchi, Atsushi Inagaki, Shohei Mizuno, Akiyoshi Takami, Shinichi Ito, et al. Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis. Annals of hematology. 2023
柳田正光, 下村良充, 水野昌平, 松田健佑, 近藤忠一, 土岐典子, 田中正嗣, 福田隆浩, 荒隆英, 内田直之, et al. 急性骨髄性白血病における同種移植前処置強度スコアの外部検証. 日本血液学会学術集会. 2023. 85回. 963-963

ｍore...

MISC (42)：

Barakat Carolyne, 勝山直哉, 佐藤由英, 小林美希, 稲垣裕一郎, 尾関和貴, 水野昌平, 冨田章裕, 赤塚美樹. 白血病に対する同種異系造血細胞移植後の養子免疫細胞移植の開発に向けたミスマッチHLA-DP分子に対する特異的T細胞クローンの樹立(Establishment of T cell clones specific for mismatched HLA-DP molecules toward development of adoptive cell therapy for leukemia following allogeneic hematopoietic cell transplantation). MHC: Major Histocompatibility Complex. 2022. 29. 2. 136-136
水野昌平. 自家造血細胞移植の輸注副反応と移植後合併症. 日本輸血細胞治療学会誌. 2022. 68. 2
水野昌平, 高見昭良, 河村浩二, 下村良充, 新井康之, 小沼貴晶, 小澤幸泰, 澤正史, 太田秀一, 高橋聡, et al. Comparison of Flu/Bu4/Mel with TBI-based MAC in AML patients with complete remission undergoing CBT. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
鈴木文乃, 内野かおり, 水野昌平, 堀尾知弘, 松久明史, 飯田悠介, 篠原早紀, 松村沙織, 金杉丈, 高杉壮一, et al. Third allogeneic HCT for the patient with NUP98::HOXA9 positive acute myeloid leukemia. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
BARAKAT Carolyne, 勝山直哉, 佐藤由英, 小林美希, 稲垣裕一郎, 水野昌平, 尾関和貴, 冨田章裕, 澤正史, 赤塚美樹. Development of mismatched HLA-DP-specific TCR-T cell therapy targeting leukemia following allogeneic. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th

ｍore...

Education (2)：

2010 - 2014 Aichi Medical University Graduate School of Medicine
2001 - 2007 Aichi Medical University School of Medicine School of Medicine

Professional career (1)：

MD, PhD (愛知医科大学)

Work history (7)：

2023/11 - 現在 Aichi Medical University
2021/04 - 2023/10 愛知医科大学病院血液内科准教授(特任)
2019/03 - 2021/03 愛知医科大学病院血液内科講師
2015/10 - 2019/02 愛知医科大学病院血液内科助教
2017/10 - 2018/09 Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Multiple Myeloma Program, Postdoctoral Fellow

Show all

Awards (9)：

2023/05 - 2022年度愛橘学術賞受賞
2023/05 - 日本造血・免疫細胞療法学会日本造血・免疫細胞療法学会Working Group Research Award
2022/04 - 愛知医科大学学内ユニット創出支援研究費獲得(代表)
2021/04 - 2021-2023年度科学研究費助成事業・若手研究(代表)
2020 - 令和2年度愛知医科大学学内ユニット創出支援研究費(分担) 免疫応答調節を基軸とした血液がんに対する治療戦略

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page